A 4-Week Dose-Ranging Study to Evaluate Antidyslipidemic Effects, Other Pharmacodynamic Effects, Safety, and Tolerability of AZD6610 with Concomitant Open-Label Simvastatin Therapy in Patients with Elevated Triglycerides, Elevated Low Density Lipid Cholesterol and Abdominal Obesity: a Randomized, Double-Blind, Placebo-Controlled, Multi-Centre, Parallel-Group Study with Fenofibrate as Reference

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].